YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

HKEX:1558.HK

8.29 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Operating Activities:
Net Income 963.1291,029.495109.401-32.798-80.621-507.028221.947617.508950.285968.424307.992634.544345.241301.86165.612214.985112.502153.24853.28682.05733.836
Depreciation & Amortization 198.367192.907203.292174.065144.628115.18873.37249.35442.92543.2633.79927.28926.96616.82914.23513.21412.95112.79614.93417.0117.986
Deferred Income Tax 000000001,651.6090327.8380000000000
Stock Based Compensation 45.13600000003.194033.540000000000
Change In Working Capital -1,511.930-565.920-117.52301,258.0890-1,654.8030-361.3780-384.7910-32.0130-77.2530-94.16723.352-17.988
Accounts Receivables -1,417.9070-530.5890-216.09501,444.0360-1,626.7680-285.0590-407.4480-76.0170-122.9010-199.602114.8460
Change In Inventory -94.0230-35.331098.5720-185.9470-28.0350-76.319022.657044.004045.6480105.435-91.4943.485
Change In Accounts Payables 00000000000000000024.17321.4730
Other Working Capital 00000000000000000000-21.473
Other Non Cash Items 733.71122.3971,800.70911.16-147.199-69.955-1,592.911672.1341,395.30145.82169.557-29.951421.254-56.60811.7569.41799.131-25.981-9.99643.4018.635
Operating Cash Flow 428.4131,244.7991,547.482152.427-200.715-461.795-39.5031,338.996736.9021,057.50583.51631.882408.67262.081159.59237.616147.331140.063-35.943165.82132.47
Investing Activities:
Investments In Property Plant And Equipment -128.132-215.586-280.424-289.646-95.023-261.262-608.377-385.782-319.574-256.702-287.934-332.105-219.564-107.472-43.974-19.013-12.554-15.45-4.504-30.966-8.868
Acquisitions Net 00000000-78.1590000-137.4020000000
Purchases Of Investments 000000000000000000-8.2500
Sales Maturities Of Investments 000000000000000000000
Other Investing Activites -535.1011,433.387-362.808-187.283-14.652-68.169-521.249-579.22209.568-1,265.616-351.067242.57697.155-245.088-299.833-4.889-316.8811.31-3.0110.148.868
Investing Cash Flow -663.2331,217.801-643.232-476.929-109.675-329.431-1,129.626-965.002-188.165-1,522.318-639.001-89.529-122.409-489.962-343.807-23.902-329.435-14.14-7.515-30.826-8.868
Financing Activities:
Debt Repayment 0-481.4020-145.690-122.7960-414.4340-3,005.15600000-72.50-5-67.5-167.4-115.735
Common Stock Issued 000000000000000000403.3700
Common Stock Repurchased 0000000-136.917-140.444-105.51500000000000
Dividends Paid 000000-219.990-569.888-150.146-241.781-74.635-316.4160-67.623000000
Other Financing Activities -1,872.389-85.912-839.693-93.024113.872-49.18992.575-85.46982.735-21.87932.488-0.523-72.12417.074-35.658-24.847846.107472.17182.06847.982115.735
Financing Cash Flow -1,872.389395.49-839.69352.666113.87273.607-127.415192.048-627.5972,727.616-209.293-75.158-388.5417.074-103.281-97.347846.107477.17182.068-119.418-72.265
Other Information:
Effect Of Forex Changes On Cash 0.013-0.024-0.111-0.188-0.0030.294-4.66910.5540.8952.6271.5251.37-13.17329.5521,353.651-1,353.65186.5544.32962.2162.21
Net Change In Cash 02,858.06664.446-272.024-196.521-717.325-1,301.213567.042-78.3062,263.698-762.157468.72-100.909-223.98-257.9461,470.018-689.648689.648290.46939.85213.547
Cash At End Of Period 3,781.6093,781.609923.543859.0971,131.1211,327.6422,044.9673,346.182,779.1382,857.444593.7461,355.903887.183988.0921,212.0721,470.0180689.648338.41347.94421.639